Ablation Verses Anti-arrhythmic Therapy for Reducing All Hospital Episodes From Recurrent Atrial Fibrillation (AVATAR-AF)
Sponsor: Imperial College London
This NA trial investigates Heart Failure and Recurrent Atrial Fibrillation and is currently completed. Imperial College London leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
8 versions recorded-
Nov 2024 — Present [monthly]
Completed NA
-
Sep 2024 — Nov 2024 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Mar 2019 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 3 earlier versions
-
Jun 2018 — Mar 2019 [monthly]
Active Not Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Oct 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Imperial College London
For direct contact, visit the study record on ClinicalTrials.gov .